Common Contracts
2 similar Indenture contracts by Theravance Biopharma, Inc.
INDENTURE dated as of February 28, 2020 by and among TRIPLE ROYALTY SUB II LLC, a Delaware limited liability company, as issuer of the Notes described herein, U.S. BANK NATIONAL ASSOCIATION, a national banking association, as initial trustee, transfer...Indenture • March 4th, 2020 • Theravance Biopharma, Inc. • Pharmaceutical preparations • New York
This INDENTURE (the “Indenture”), dated as of February 28, 2020, is by and among TRIPLE ROYALTY SUB II LLC, a Delaware limited liability company, as issuer of the Notes described herein (the “Issuer”), U.S. BANK NATIONAL ASSOCIATION, a national banking association, as initial trustee, transfer agent, paying agent, registrar and calculation agent of the Notes described herein (the “Trustee”) and solely with respect to Section 2.11(o) and Section 2.11(p), THERAVANCE BIOPHARMA, INC., a Cayman Islands exempted company (“Theravance Biopharma”).
INDENTURE dated as of November 30, 2018 by and between TRIPLE ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as initial trustee,...Indenture • December 3rd, 2018 • Theravance Biopharma, Inc. • Pharmaceutical preparations • New York
This INDENTURE, dated as of November 30, 2018, is by and between TRIPLE ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as initial trustee, transfer agent, paying agent, registrar and calculation agent of the Notes described herein.
